CERVICAL CANCER: The Role of Communication in Fighting Stigma and Misinformation.
On the evening of September 18th, 2024, the #HerReasonForBeing X Space series hosted a vital discussion on the Role of Communication in the fight against Stigma and Misinformation surrounding Cervical Cancer. Moderated by Ms. Valerie Aura, this session brought together a panel of experienced professionals and survivors to explore how effective communication strategies can impact […]
A Call to Prioritize Gynecologic Health
Statement on World Gynecologic Oncology Day As we mark World Gynecologic Oncology Day, we at Being Africa urge the Government of Kenya and all civil society organizations to rally together in the fight against stigma and misinformation surrounding gynecologic health. Today, we confront an urgent challenge: the barriers that prevent women from seeking regular screening […]
Overcoming Barriers to Cervical Cancer Screening.
On September 11, 2024, Being Africa hosted a Twitter Space under the “Her Reason for Being” series to discuss strategies for overcoming barriers to cervical cancer screening. The session was moderated by Ms. Valerie Aura, with panelists Ms. Elizabeth Makena and Ms. Martha Wanjiru sharing their expertise and insights. Valerie opened the session by highlighting […]
Cervical Cancer: Advocacy for Better Screening, Treatment, and Other Prevention Strategies
On August 21st, 2024, Being Africa hosted a pivotal X Space discussion centered on “Advocacy for Better Access to Screening, Treatment, and Other Prevention Strategies” for cervical cancer. This event featured profound insights from Ms. Phoebe Ongadi, Executive Director of the Kenyan Network of Cancer Organizations (KENCO), and Mr. Joel Gitali, Chairman of the Kenya […]
What’s New in Cervical Cancer Research: A Virtual Dialogue
On the 7th of August 2024, Dr. Afrin Shaffi, a distinguished gynecologic oncologist currently based in Malawi, provided invaluable insights during a #HerReasonForBeing X Space dedicated to cervical cancer awareness. This session focused on the critical aspects of cervical cancer prevention, screening, and treatment, drawing attention to the alarming statistics and available preventive strategies. Cervical […]
Empowering Communities: Cervical Cancer Awareness Event
On 10th May, 2024, we held a community sensitization event at Kibera South Health Centre, marking a significant step towards raising awareness and understanding about cervical cancer. This event aimed to educate both Community Health Promoters (CHPs) and community members about the importance of early detection, prevention, and treatment of cervical cancer. The Need for […]
Cervical Cancer Screening Event at Undugu Level 2: A Day of Awareness and Hope
A crucial health event unfolded on 29th and 30th April, 2024 at Undugu Level 2 facility, located within Nyayo High-rise ward in Lang’ata Sub-County. This cervical cancer screening event aimed at combating cervical cancer, a disease that claims far too many lives each year. As advocates for women’s health, we eagerly attended the event to […]
How You Can Get Involved
Cervical cancer remains a significant health concern worldwide, impacting the lives of millions of women each year. Beyond its physical effects, the stigma surrounding cervical cancer often goes unnoticed, yet it can profoundly affect individuals and communities. However, there is power in collective action to challenge this stigma, raise awareness, promote screening, vaccination and provide […]
Get Screened
Cervical cancer is a significant public health concern worldwide, with approximately 570,000 new cases diagnosed each year, according to the World Health Organization. Despite being highly preventable and curable when detected early, cervical cancer remains a leading cause of cancer-related deaths among women in many parts of the world. However, with the advent of effective screening methods, such as Pap smears and HPV tests, the tide is turning in the fight against this disease.
Cervical cancer screening plays a crucial role in detecting abnormal changes in the cells of the cervix before they develop into cancer or progress to advanced stages. The primary aim of screening is to identify pre-cancerous lesions early, allowing for timely intervention and treatment to prevent the development of invasive cancer.
The Pap smear, also known as Pap test or cervical cytology, has been the gold standard for cervical cancer screening for decades. During a Pap smear, a healthcare provider collects cells from the cervix and examines them under a microscope for any abnormalities. If abnormal cells are detected, further diagnostic tests, such as colposcopy or biopsy, may be recommended to confirm the presence of pre-cancerous or cancerous changes.
In recent years, the introduction of Human Papillomavirus (HPV) testing has revolutionized cervical cancer screening. HPV is a common sexually transmitted infection that is responsible for nearly all cases of cervical cancer. HPV testing involves checking for the presence of high-risk strains of the virus in cervical cells. Combined with Pap smear, HPV testing provides a more sensitive and accurate screening approach, allowing for better risk stratification and earlier detection of cervical abnormalities.
The frequency and age at which women should undergo cervical cancer screening depend on various factors, including their age, risk factors, and screening history. Generally, guidelines recommend that women begin screening at age 21 and undergo regular screenings every 3-5 years, depending on the screening method used and individual risk factors.
Despite the proven effectiveness of cervical cancer screening, disparities in access to screening services persist, particularly in low- and middle-income countries. Limited access to healthcare facilities, lack of awareness about the importance of screening, and cultural barriers are among the factors contributing to low screening rates in these regions. Efforts to improve access to screening through outreach programs, community education initiatives, and the integration of screening services into primary healthcare are essential in reducing the burden of cervical cancer globally.
It is important to emphasize that cervical cancer screening is not a one-size-fits-all approach. Healthcare providers must consider individual risk factors, preferences, and screening guidelines when recommending screening intervals and methods for their patients. Additionally, vaccination against HPV, which is recommended for adolescents and young adults, plays a crucial role in preventing HPV infections and reducing the risk of cervical cancer in the long term.
In conclusion, cervical cancer screening is a cornerstone of cervical cancer prevention and early detection. Regular screenings with Pap smear, HPV testing, or a combination of both can significantly reduce the incidence and mortality associated with this disease. By increasing awareness, improving access to screening services, and implementing evidence-based screening strategies, we can work towards a future where cervical cancer is no longer a major health threat for women worldwide. Early detection saves lives, and every woman deserves the opportunity to protect her health through timely screening.
Have you scheduled your regular screenings with your healthcare provider yet?
What is Cervical Cancer?
Cervical cancer is a type of cancer that starts in the cervix, the lower part of the uterus that connects to the vagina. It is most common among women aged 35-49 years. However, all women are at risk for cervical cancer. Cervical cancer is caused by the Human papillomavirus (HPV), a sexually transmitted infection. Most […]
